Infliximab/ipilimumab/nivolumabDrug induced acute liver injury and enterocolitis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1749卷 / 1期

关键词：

D O I：

10.1007/s40278-019-60684-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：219 / 219

相关论文

共 50 条

[1] Ipilimumab/nivolumabDrug-induced liver injury: case report
Reactions Weekly, 2019, 1753 (1) : 203 - 203
[2] Ipilimumab/nivolumabDrug-induced liver injury and thyroiditis with hypothyroidism: case report
Reactions Weekly, 2021, 1877 (1) : 204 - 204
[3] Infliximab/ipilimumab/nivolumabColitis and acute drug induced liver injury: case report
Reactions Weekly, 2019, 1754 (1) : 194 - 194
[4] NivolumabDrug-induced liver injury: case report
Reactions Weekly, 2019, 1761 (1) : 273 - 273
[5] Ipilimumab/nivolumabDrug induced interstitial pneumonia: case report
Reactions Weekly, 2022, 1911 (1) : 248 - 248
[6] Ipilimumab/NivolumabDrug induced diaphragmatic myopathy: case report
Reactions Weekly, 2024, 2037 (1) : 217 - 217
[7] Ipilimumab/nivolumabDrug-induced hypersensitivity syndrome: case report
Reactions Weekly, 2022, 1920 (1) : 266 - 266
[8] PazopanibAcute liver injury and enterocolitis: case report
Reactions Weekly, 2017, 1664 (1) : 226 - 226
[9] Ipilimumab/nivolumabImmunomodulatory enterocolitis: case report
Reactions Weekly, 2018, 1710 (1) : 179 - 179
[10] Ipilimumab/nivolumabSevere enterocolitis: case report
Reactions Weekly, 2021, 1865 (1) : 240 - 240

← 1 2 3 4 5 →